Genmab A GMAB
NASDAQ GMAB
$39.55 +0.48 (+1.23%)
As of: Oct 21, 2026 · 2:50 PM EDT

Genmab A (GMAB) Common Stock Issued (2023 - 2026)

Updated

Analysis

Genmab A (GMAB) Common Stock Issued (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,136.71 Bn 1,105.29 Bn 19.71 Bn -
2 Johnson & Johnson 617.55 Bn 536.07 Bn 17.26 Bn 359.00 Mn
3 AbbVie 501.02 Bn 474.13 Bn 12.70 Bn -
4 Merck 368.18 Bn 322.56 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 297.89 Bn 261.88 Bn 11.24 Bn -
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn 6.00 Mn
7 Amgen 236.60 Bn 191.99 Bn 7.24 Bn -
8 Gilead Sciences 190.55 Bn 164.75 Bn 6.22 Bn 9.00 Mn
9 Pfizer 169.77 Bn 116.42 Bn 10.94 Bn -
10 Genmab A 2.56 Bn -2.81 Bn 1.07 Bn 1.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.00 Mn
Mar 31, 2026 2.00 Mn
Mar 31, 2025 1.00 Mn
Mar 31, 2024 9.00 Mn
Dec 31, 2023 -122.00 Mn
Mar 31, 2023 32.00 Mn
API Access

Genmab A Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=GMAB&period=max&api_key=YOUR_API_KEY